Oslo, Norway, 6 February 2026. Reference is made to the stock exchange
announcement published 5 February 2026 by EXACT Therapeutics AS (the "Company",
Euronext Growth ticker: EXTX), a clinical-stage precision medicine company,
announcing that: GE Medical Holding AB ("GEMH"), a subsidiary of GE HealthCare
Technologies Inc., confirmed that it will exercise all of its 26,973,169
warrants and that remaining warrant holders therefore will have until 26
February 2026 to exercise their warrants (15 business days). Reference is also
made to the Company's stock exchange announcement from the same day, confirming
the exercise of warrants by certain leading shareholders and primary insiders in
the Company, that together with GEMH, represent approximately 75% of the
warrants issued.
In conjunction with the ongoing warrants exercise, the Company will host a
global investor call (in English) on Wednesday, 11 February 2026 at 3 PM
CET/9:00 AM EST. The presentation will be held by the Company's CEO, Per Walday